| 000 | 02845nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 76500 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040227.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 131004s2013 gw | s |||| 0|eng d | ||
| 020 | _a9783642386640 | ||
| 024 | 7 |
_a10.1007/978-3-642-38664-0 _2doi |
|
| 050 | 4 |
_aRM388 _b.P43 2013 EB |
|
| 082 | 0 | 4 | _a615 |
| 245 | 0 | 0 |
_aPharmacotherapy of Pulmonary Hypertension _cedited by Marc Humbert, Oleg V. Evgenov, Johannes-Peter Stasch |
| 264 | 1 |
_aBerlin, Heidelberg _bSpringer International Publishing _c2013 |
|
| 300 |
_a1 recurso en línea (IX, 576 p.) _b66 ilustraciones, 56 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 1 |
_aHandbook of Experimental Pharmacology _x0171-2004 _v218 |
|
| 505 | 0 | _a Preface.- Part I. Pulmonary hypertension: conceptual bases of the disease. Pulmonary hypertension: definition, classification, and epidemiology. Pulmonary hypertension: pathophysiology and signalling pathways. Pulmonary hypertension: pathology. Pulmonary hypertension: biomarkers. Pulmonary hypertension: animal models -- Part II. Pulmonary hypertension: established therapies. General supportive care. Calcium channel blockers. Prostacyclins. Endothelin receptor antagonists. Phosphodiesterase 5 inhibitors -- Part III. Pulmonary hypertension: novel pathways and emerging therapies Soluble guanylate cyclase stimulators. Therapeutics targeting dysregulated redox equilibrium and endothelial dysfunction (NOXs, sGC activators, GSNOR). Rho-kinase inhibitors. Serotonin transporters and serotonin receptors. PDGF inhibitors. Novel anti-proliferative strategies beyond imatinib. Immunosuppressive agents. Vasoactive peptides. Inhibitors of cGMP/cAMP metabolism (MRP4, MRP5, PDE1). Old targets re-visited. Stem cells and cell based therapy -- Part IV. Conclusions and Outlook. Pulmonary hypertension: evidence-based management in the modern era and future directions | |
| 942 |
_2lcc _cLE |
||
| 988 | _aEBOOK, EBSPRINGERrevisando | ||
| 650 | 7 |
_aFarmacología respiratoria _9158438 _0comprobar BNE20011227327 _2embne |
|
| 700 | 1 |
_aHumbert, Marc _eeditor literario _985612 _0Local |
|
| 700 | 1 |
_aEvgenov, Oleg V. _eeditor literario _0Local _985613 |
|
| 700 | 1 |
_aStasch, Johannes-Peter _eeditor literario _985614 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-38664-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783642386640 | ||
| 907 |
_a.b12821184 _b10-10-17 _c01-10-14 |
||
| 998 |
_am _a_alco _a_vill _b19-09-17 _cm _dz _eu _feng _ggw _h0 |
||
| 945 |
_aRM388 .P43 2013 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11550399 _z06-04-17 |
||
| 999 |
_c76500 _d76500 _x1 |
||